A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Locations
  • Clinical Study Site, Birmingham, Alabama, United States
  • Clinical Study Site, Phoenix, Arizona, United States
  • Clinical Study Site, Scottsdale, Arizona, United States
  • Clinical Study Site, Los Angeles, California, United States
  • Clinical Study Site, San Francisco, California, United States
  • Clinical Study Site, San Francisco, California, United States
  • Clinical Study Site, Washington D.C., District of Columbia, United States
  • Clinical Study Site, Maitland, Florida, United States
  • Clinical Study Site, Tampa, Florida, United States
  • Clinical Study Site, Honolulu, Hawaii, United States
  • Clinical Study Site, Chicago, Illinois, United States
  • Clinical Study Site, Edwardsville, Illinois, United States
  • Clinical Study Site, Indianapolis, Indiana, United States
  • Clinical Study Site, Kansas City, Kansas, United States
  • Clinical Study Site, Burlington, Massachusetts, United States
  • Clinical Study Site, East Lansing, Michigan, United States
  • Clinical Study Site, Omaha, Nebraska, United States
  • Cinical Study Site, Lebanon, New Hampshire, United States
  • Clinical Study Site, New York, New York, United States
  • Clinical Study Site, New York, New York, United States
  • Clinical Study Site, Cincinnati, Ohio, United States
  • Clinical Study Site, Columbus, Ohio, United States
  • Clinical Study Site, Portland, Oregon, United States
  • Clinical Study Site, Dallas, Texas, United States
  • Clinical Study Site, Denton, Texas, United States
  • Cinical Study Site, Houston, Texas, United States
  • Texas Locations, Houston, Texas, United States
  • Clinical Study Site, Round Rock, Texas, United States
  • Clinical Study Site, Sugar Land, Texas, United States
  • Clinical Study Site, Seattle, Washington, United States
  • Cinical Study Site, Buenos Aires, Buenos Aires, Argentina
  • Cinical Study Site, Rosario, Santa Fe Province, Argentina
  • Cinical Study Site #3, Buenos Aires, Argentina
  • Cinical Study Site #4, Buenos Aires, Argentina
  • Clinical Study Site #2, Buenos Aires, Argentina
  • Clinical Study Site, Buenos Aires, Argentina
  • Cinical Study Site #2, San Miguel de Tucumán, Argentina
  • Clinical Study Site, San Miguel de Tucumán, Argentina
  • Clinical Study Site, Randwick, New South Wales, Australia
  • Cinical Study Site, Saint Leonards, New South Wales, Australia
  • Cinical Study Site, Sydney, New South Wales, Australia
  • Cinical Study Site, Southport, Queensland, Australia
  • Clinical Study Site, Melbourne, Victoria, Australia
  • Cinical Study Site, Brussels, Belgium
  • Cinical Study Site, Rio de Janeiro, Rio de Janeiro, Brazil
  • Clinical Study Site, Campinas, São Paulo, Brazil
  • Cinical Study Site, Natal, Brazil
  • Cinical Study Site, Porto Alegre, Brazil
  • Cinical Study Site, Salvador, Brazil
  • Cinical Study Site, São Paulo, Brazil
  • Cinical Study Site, São Paulo, Brazil
  • Cinical Study Site, Sofia, Bulgaria
  • Clinical Study Site, Sofia, Bulgaria
  • Clinical Study Site, Hefei, Anhui, China
  • Clinical Study Site, Guangzhou, Guangdong, China
  • Clinical Study Site, Changsha, Hu'Nan, China
  • Clinical Study Site, Changsha, Hu'Nan, China
  • Clinical Study Site, Wuhan, Hubei, China
  • Clinical Study Site, Chifeng, Inner Mongolia, China
  • Clinical Study Site, Suzhou, Jiangsu, China
  • Clinical Study Site, Beijing, China
  • Clinical Study Site, Beijing, China
  • Clinical Study Site, Chengdu, China
  • Clinical Study Site, Fujian, China
  • Clinical Study Site, Guangdong, China
  • Clinical Study Site, Guangzhou, China
  • Clinical Study Site, Jilin, China
  • Clinical Study Site, Shanghai, China
  • Clinical Study Site, Shanghai, China
  • Clinical Study Site, Sichuan, China
  • Clinical Study Site, Taiyuan, China
  • Clinical Study Site, Wuhan, China
  • Cinical Study Site, Medellín, Antioquia, Colombia
  • Cinical Study Site, Antioquia, Colombia
  • Cinical Study Site, Medellín, Colombia
  • Cinical Study Site, Osijek, Croatia
  • Clinical Study Site, Aarhus, Denmark
  • Clinical Study Site, Copenhagen, Denmark
  • Clinical Study Site, Bordeaux, France
  • Cinical Study Site, Brest, France
  • Clinical Study Site, Bron, France
  • Clinical Study Site, Clermont-Ferrand, France
  • Clinical Study Site, Libourne, France
  • Clinical Study Site, Marseille, France
  • Clinical Study Site, Nice, France
  • Clinical Study Site, Paris, France
  • Clinical Study Site, Paris, France
  • Clinical Study Site, Strasbourg, France
  • Cinical Study Site, Tours, France
  • Clinical Study Site, Tours, France
  • Clinical Study Site, Tbilisi, Georgia
  • Clinical Study Site, Sande, Lower Saxony, Germany
  • Clinical Study Site, Aachen, Germany
  • Cinical Study Site, Greifswald, Germany
  • Clinical Study Site, Rüdersdorf, Germany
  • Clinical Study Site, Sande, Germany
  • Cinical Study Site, Beersheba, Israel
  • Cinical Study Site, Haifa, Israel
  • Cinical Study Site, Safed, Israel
  • Clinical Study Site, Bergamo, Italy
  • Clinical Study Site, Bologna, Italy
  • Cinical Study Site, Genova, Italy
  • Cinical Study Site, Gussago, Italy
  • Cinical Study Site, Milan, Italy
  • Cinical Study Site, Milan, Italy
  • Cinical Study Site, Modena, Italy
  • Clinical Study Site, Pavia, Italy
  • Clinical Study Site, Ponderano, Italy
  • Clinical Study Site, Roma, Italy
  • Clinical Study Site #2, Roma, Italy
  • Clinical Study Site, Roma, Italy
  • Cinical Study Site, Terni, Italy
  • Cinical Study Site, Riga, Latvia
  • Clinical Study Site, Riga, Latvia
  • Cinical Study Site, Kota Kinabalu, Sabah, Malaysia
  • Cinical Study Site, Kuching, Sarawak, Malaysia
  • Cinical Study Site, George Town, Malaysia
  • Cinical Study Site, Johor Bahru, Malaysia
  • Cinical Study Site, Kota Kinabalu, Malaysia
  • Cinical Study Site, Kuala Lumpur, Malaysia
  • Cinical Study Site, Kuala Lumpur, Malaysia
  • Cinical Study Site, Kuala Lumpur, Malaysia
  • Cinical Study Site, Kuching, Malaysia
  • Cinical Study Site, Sungai Buloh, Malaysia
  • Cinical Study Site, Utrecht, Netherlands
  • Clinical Study Site, Skopje, North Macedonia
  • Cinical Study Site, Cebu City, Philippines
  • Cinical Study Site, Iloilo City, Philippines
  • Clinical Study Site, Bydgoszcz, Poland
  • Clinical Study Site, Krakow, Poland
  • Clinical Study Site, Lublin, Poland
  • Clinical Study Site, Lublin, Poland
  • Clinical Study Site, Lublin, Poland
  • Cinical Study Site, Warsaw, Poland
  • Clinical Study Site, Wroclaw, Poland
  • Clinical Study Site, Bucharest, Romania
  • Cinical Study Site, Belgrade, Serbia
  • Clinical Study Site, Belgrade, Serbia
  • Clinical Study Site, Kragujevac, Serbia
  • Clinical Study Site, Niš, Serbia
  • Cinical Study Site, Daegu, South Korea
  • Cinical Study Site, Daejeon, South Korea
  • Cinical Study Site #2, Seoul, South Korea
  • Cinical Study Site #3, Seoul, South Korea
  • Cinical Study Site, Seoul, South Korea
  • Cinical Study Site, Yangsan, South Korea
  • Clinical Study Site, Barcelona, Barcelona, Spain
  • Clinical Study Site, Alicante, Spain
  • Clinical Study Site, Barcelona, Spain
  • Cinical Study Site, Barcelona, Spain
  • Clinical Study Site, Bilbao, Spain
  • Cinical Study Site #2, Bangkok, Thailand
  • Cinical Study Site, Bangkok, Thailand
  • Cinical Study Site, Hat Yai, Thailand
  • Cinical Study Site, Khlong Luang, Thailand
  • Cinical Study Site, Khon Kaen, Thailand
  • Cinical Study Site, Khon Kaen, Thailand
  • Clinical Study Site, Oxford, United Kingdom